Procter & Gamble Company (The) $PG Shares Bought by OFI Invest Asset Management

OFI Invest Asset Management grew its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 404,877 shares of the company’s stock after purchasing an additional 10,058 shares during the quarter. Procter & Gamble accounts for 0.7% of OFI Invest Asset Management’s portfolio, making the stock its 28th largest position. OFI Invest Asset Management’s holdings in Procter & Gamble were worth $58,023,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Procter & Gamble by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock valued at $36,050,992,000 after purchasing an additional 1,419,322 shares during the period. State Street Corp increased its holdings in shares of Procter & Gamble by 0.4% in the third quarter. State Street Corp now owns 100,634,824 shares of the company’s stock valued at $15,462,541,000 after buying an additional 370,872 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Procter & Gamble by 8.3% in the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company’s stock valued at $3,510,955,000 after buying an additional 1,752,481 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Procter & Gamble by 1.2% in the third quarter. Legal & General Group Plc now owns 16,556,061 shares of the company’s stock valued at $2,543,839,000 after buying an additional 189,968 shares in the last quarter. Finally, Fisher Asset Management LLC increased its holdings in shares of Procter & Gamble by 0.4% in the third quarter. Fisher Asset Management LLC now owns 11,008,454 shares of the company’s stock valued at $1,691,449,000 after buying an additional 40,941 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Chairman Jon R. Moeller sold 162,232 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total value of $26,354,588.40. Following the transaction, the chairman directly owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. This represents a 33.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,827 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the completion of the transaction, the insider directly owned 12,639 shares in the company, valued at $2,026,158.09. This trade represents a 50.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 348,618 shares of company stock valued at $55,462,643 in the last three months. Company insiders own 0.20% of the company’s stock.

Procter & Gamble Price Performance

PG opened at $145.00 on Thursday. The stock has a fifty day moving average of $153.23 and a 200-day moving average of $149.32. The firm has a market capitalization of $336.98 billion, a P/E ratio of 21.48, a PEG ratio of 5.04 and a beta of 0.41. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $171.65. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 earnings per share. Equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio is 62.67%.

Analyst Ratings Changes

Several research analysts have issued reports on PG shares. Erste Group Bank cut Procter & Gamble from a “buy” rating to a “hold” rating in a report on Tuesday, March 24th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Friday, March 27th. The Goldman Sachs Group dropped their price target on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a report on Wednesday. Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the company from $156.00 to $179.00 in a report on Tuesday, December 16th. Finally, Barclays set a $155.00 price target on Procter & Gamble in a report on Friday, January 16th. Twelve research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $164.79.

Read Our Latest Stock Analysis on PG

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: UBS cut its price target to $166 but kept a “buy” rating, signaling continued conviction in P&G’s recovery and leaving room for upside from current levels. UBS Lowers PT to $166
  • Positive Sentiment: Jim Cramer/CNBC highlighted P&G’s “lifeblood” innovation strategy as key to a turnaround — positive narrative that can support investor confidence in longer?term margin and growth improvements. CNBC: P&G Strategy
  • Positive Sentiment: P&G announced a multi?year, multi?brand partnership with the WNBA — a brand and marketing play that may aid reach and consumer engagement across key demographics. P&G WNBA Partnership
  • Neutral Sentiment: P&G named a new health care CEO as a 33?year veteran retires — a routine leadership transition in a major business unit; watch for guidance or strategic comments from the new leader but immediate impact is likely limited. Health Care CEO Change
  • Neutral Sentiment: Market commentary and index trackers continue to follow PG closely (Russell 1000 coverage), increasing liquidity and attention but not changing fundamentals. Russell 1000 Tracking
  • Negative Sentiment: Goldman Sachs trimmed its price target to $155 and moved to a “neutral” rating — a downgrade in expectations that can weigh on near?term sentiment. Goldman Lowers PT to $155
  • Negative Sentiment: Piper Sandler cut its target to $142 (neutral), signaling more conservative expectations and adding downside pressure for short?term traders. Piper Sandler Lowers PT to $142
  • Negative Sentiment: Earlier analyst downgrades and commentary pushed the stock lower on prior sessions (reports noted a ~1.1% drop following a downgrade), reflecting sensitivity to revisions in analyst forecasts. Price Down After Downgrade

About Procter & Gamble

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.